PREVENTING AND TREATING COMPOSITION FOR DEVELOPMENT OF CLINICAL SYMPTOM IN DISEASE CAUSED BY MITOCHONDRIA FUNCTIONAL ABNORMALITY

PROBLEM TO BE SOLVED: To provide an excellent preventing and treating agent for the development of clinical symptoms in diseases caused by mitochondria functional abnormality. SOLUTION: This preventing and treating agent for the development of the clinical symptoms in the diseases caused by the mito...

Full description

Saved in:
Bibliographic Details
Main Authors KOGA YASUTOSHI, NAKANISHI MASATO
Format Patent
LanguageEnglish
Published 02.07.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide an excellent preventing and treating agent for the development of clinical symptoms in diseases caused by mitochondria functional abnormality. SOLUTION: This preventing and treating agent for the development of the clinical symptoms in the diseases caused by the mitochondria functional abnormality is characterized by containing L-arginine as an active ingredient and as an oral administration composition. COPYRIGHT: (C)2004,JPO&NCIPI
Bibliography:Application Number: JP20020378176